Allworth Financial
PLYX icon

Allworth Financial’s Polaryx Therapeutics Inc PLYX Stock Holding History

Allworth Financial’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.6K Hold
7,727
– – ﹤0.01% 3315
2026
Q2 		$20.6K Buy
+7,727
New +$30.3K ﹤0.01% 3179

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $87.3B AUM 22.01% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $225B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Allworth Financial's PLYX Position: Q3 2026 in Review

Allworth Financial held its Polaryx Therapeutics Inc (PLYX) position steady in Q3 2026 at 7,727 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

Allworth Financial first reported a position in PLYX in Q2 2026 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold PLYX as of Q3 2026.

  • Allworth Financial held 7,727 shares of Polaryx Therapeutics Inc worth $20.6K as of Q3 2026.
  • Allworth Financial left its Polaryx Therapeutics Inc share count unchanged in Q3 2026.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #3315 holding.
  • Allworth Financial first reported a position in Polaryx Therapeutics Inc in Q2 2026 and has held it in 2 quarters since.
  • 11 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.